News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

BMS’ Opdivo fails late-stage brain cancer test

Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

  There are many ways to use the checkpoint inhibitors.  This study shows that using Opdivo instead of Temodar during radiation for newly diagnosed is not helping.  This doesn't mean the drug is bad - just that it isn't being used correctly.  There are other trials going on that hopefully will show us how best to use this class of drug!

Posted on: 05/13/2019

BMS’ Opdivo fails late-stage brain cancer test


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557